Unresolved disorder model. using A ATOM 1313 N AASP 168 3.186 -0.708 -15.320 0.50 17.27 N Unresolved disorder model. using A ATOM 1314 N BASP 168 3.197 -0.723 -15.379 0.50 17.38 N Unresolved disorder model. using A ATOM 1315 CA AASP 168 2.998 -1.901 -16.127 0.50 18.42 C Unresolved disorder model. using A ATOM 1316 CA BASP 168 3.153 -1.947 -16.174 0.50 18.63 C Unresolved disorder model. using A ATOM 1317 C AASP 168 1.933 -1.595 -17.171 0.50 19.73 C Unresolved disorder model. using A ATOM 1318 C BASP 168 1.988 -1.860 -17.176 0.50 19.91 C Unresolved disorder model. using A ATOM 1319 O AASP 168 0.767 -1.382 -16.845 0.50 19.79 O Unresolved disorder model. using A ATOM 1320 O BASP 168 0.824 -2.041 -16.812 0.50 20.05 O Unresolved disorder model. using A ATOM 1321 CB AASP 168 2.550 -3.075 -15.271 0.50 18.46 C Unresolved disorder model. using A ATOM 1322 CB BASP 168 3.084 -3.186 -15.280 0.50 18.65 C Unresolved disorder model. using A ATOM 1323 CG AASP 168 2.264 -4.314 -16.090 0.50 17.72 C Unresolved disorder model. using A ATOM 1324 CG BASP 168 4.140 -4.229 -15.639 0.50 18.76 C Unresolved disorder model. using A ATOM 1325 OD1AASP 168 2.355 -4.243 -17.335 0.50 17.83 O Unresolved disorder model. using A ATOM 1326 OD1BASP 168 4.101 -4.738 -16.782 0.50 18.08 O Unresolved disorder model. using A ATOM 1327 OD2AASP 168 1.958 -5.364 -15.490 0.50 17.00 O Unresolved disorder model. using A ATOM 1328 OD2BASP 168 5.007 -4.540 -14.785 0.50 17.17 O Unresolved disorder model. using A ATOM 1856 CA AGLU 245 34.663 -16.787 -11.446 0.50 21.05 C Unresolved disorder model. using A ATOM 1857 CA BGLU 245 34.668 -16.704 -11.434 0.50 21.04 C Unresolved disorder model. using A ATOM 1860 CB AGLU 245 35.182 -15.794 -10.405 0.50 21.16 C Unresolved disorder model. using A ATOM 1861 CB BGLU 245 35.109 -15.527 -10.552 0.50 21.22 C Unresolved disorder model. using A ATOM 1862 CG AGLU 245 36.515 -16.215 -9.800 0.50 21.89 C Unresolved disorder model. using A ATOM 1863 CG BGLU 245 34.848 -14.135 -11.151 0.50 21.65 C Unresolved disorder model. using A ATOM 1864 CD AGLU 245 36.382 -17.384 -8.835 0.50 22.97 C Unresolved disorder model. using A ATOM 1865 CD BGLU 245 35.762 -13.816 -12.319 0.50 22.16 C Unresolved disorder model. using A ATOM 1866 OE1AGLU 245 36.679 -18.533 -9.229 0.50 22.41 O Unresolved disorder model. using A ATOM 1867 OE1BGLU 245 36.970 -14.155 -12.241 0.50 22.62 O Unresolved disorder model. using A ATOM 1868 OE2AGLU 245 35.972 -17.151 -7.676 0.50 23.94 O Unresolved disorder model. using A ATOM 1869 OE2BGLU 245 35.272 -13.226 -13.311 0.50 20.75 O Unresolved disorder model. using A ATOM 2014 CA AGLN 264 36.013 -15.837 -26.744 0.50 37.04 C Unresolved disorder model. using A ATOM 2015 CA BGLN 264 36.051 -15.841 -26.748 0.50 36.96 C Unresolved disorder model. using A ATOM 2018 CB AGLN 264 37.326 -16.273 -26.078 0.50 37.00 C Unresolved disorder model. using A ATOM 2019 CB BGLN 264 37.446 -16.207 -26.216 0.50 36.84 C Unresolved disorder model. using A ATOM 2020 CG AGLN 264 37.136 -17.052 -24.777 0.50 36.57 C Unresolved disorder model. using A ATOM 2021 CG BGLN 264 37.610 -17.630 -25.698 0.50 36.09 C Unresolved disorder model. using A ATOM 2022 CD AGLN 264 35.790 -17.764 -24.709 0.50 36.25 C Unresolved disorder model. using A ATOM 2023 CD BGLN 264 36.988 -17.834 -24.327 0.50 35.59 C Unresolved disorder model. using A ATOM 2024 OE1AGLN 264 34.811 -17.326 -25.323 0.50 35.78 O Unresolved disorder model. using A ATOM 2025 OE1BGLN 264 35.779 -18.025 -24.207 0.50 35.87 O Unresolved disorder model. using A ATOM 2026 NE2AGLN 264 35.732 -18.860 -23.951 0.50 35.76 N Unresolved disorder model. using A ATOM 2027 NE2BGLN 264 37.817 -17.815 -23.288 0.50 34.41 N 1